These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 39286971)

  • 1. SARS-CoV-2 Delta and Omicron variants resist spike cleavage by human airway trypsin-like protease.
    Ren W; Hong W; Yang J; Zou J; Chen L; Zhou Y; Lei H; Alu A; Que H; Gong Y; Bi Z; He C; Fu M; Peng D; Yang Y; Yu W; Tang C; Huang Q; Yang M; Li B; Li J; Wang J; Ma X; Hu H; Cheng W; Dong H; Lei J; Chen L; Zhou X; Li J; Wang W; Lu G; Shen G; Yang L; Yang J; Wang Z; Jia G; Su Z; Shao B; Miao H; Yiu-Nam Lau J; Wei Y; Zhang K; Dai L; Lu S; Wei X
    J Clin Invest; 2024 Sep; 134(18):. PubMed ID: 39286971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases.
    Chaudhry MZ; Eschke K; Hoffmann M; Grashoff M; Abassi L; Kim Y; Brunotte L; Ludwig S; Kröger A; Klawonn F; Pöhlmann SH; Cicin-Sain L
    J Virol; 2022 Mar; 96(5):e0218621. PubMed ID: 35019723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Omicron subvariants progressively adapt to human cells with altered host cell entry.
    Sakurai Y; Okada S; Ozeki T; Yoshikawa R; Kinoshita T; Yasuda J
    mSphere; 2024 Sep; 9(9):e0033824. PubMed ID: 39191389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity.
    Meng B; Abdullahi A; Ferreira IATM; Goonawardane N; Saito A; Kimura I; Yamasoba D; Gerber PP; Fatihi S; Rathore S; Zepeda SK; Papa G; Kemp SA; Ikeda T; Toyoda M; Tan TS; Kuramochi J; Mitsunaga S; Ueno T; Shirakawa K; Takaori-Kondo A; Brevini T; Mallery DL; Charles OJ; ; ; ; Bowen JE; Joshi A; Walls AC; Jackson L; Martin D; Smith KGC; Bradley J; Briggs JAG; Choi J; Madissoon E; Meyer KB; Mlcochova P; Ceron-Gutierrez L; Doffinger R; Teichmann SA; Fisher AJ; Pizzuto MS; de Marco A; Corti D; Hosmillo M; Lee JH; James LC; Thukral L; Veesler D; Sigal A; Sampaziotis F; Goodfellow IG; Matheson NJ; Sato K; Gupta RK
    Nature; 2022 Mar; 603(7902):706-714. PubMed ID: 35104837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity.
    Khatri R; Siddqui G; Sadhu S; Maithil V; Vishwakarma P; Lohiya B; Goswami A; Ahmed S; Awasthi A; Samal S
    Med Microbiol Immunol; 2023 Feb; 212(1):103-122. PubMed ID: 36583790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation.
    Hörnich BF; Großkopf AK; Schlagowski S; Tenbusch M; Kleine-Weber H; Neipel F; Stahl-Hennig C; Hahn AS
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33608407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virological and Mitochondriopathogical Characteristics of the SARS-CoV-2 Omicron XBB.1.16 Spike.
    Fang L; Kang X; Hong Q; Xue C; Pan L; Chen J; Tang C; Sun L; Xu X; Yuan J; Du Y; Xu A
    ACS Appl Mater Interfaces; 2024 Jun; 16(23):29716-29727. PubMed ID: 38814480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance.
    Lista MJ; Winstone H; Wilson HD; Dyer A; Pickering S; Galao RP; De Lorenzo G; Cowton VM; Furnon W; Suarez N; Orton R; Palmarini M; Patel AH; Snell L; Nebbia G; Swanson C; Neil SJD
    J Virol; 2022 Dec; 96(23):e0125022. PubMed ID: 36350154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating Cell Entry Potentials of SARS-CoV-2 Omicron Subvariants on Human Lung Epithelium Cells.
    Katte RH; Ao Y; Xu W; Han Y; Zhong G; Ghimire D; Florence J; Tucker TA; Lu M
    Viruses; 2024 Mar; 16(3):. PubMed ID: 38543757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential glycosylations at the multibasic cleavage site of SARS-CoV-2 spike protein regulate viral activity.
    Wang S; Ran W; Sun L; Fan Q; Zhao Y; Wang B; Yang J; He Y; Wu Y; Wang Y; Chen L; Chuchuay A; You Y; Zhu X; Wang X; Chen Y; Wang Y; Chen YQ; Yuan Y; Zhao J; Mao Y
    Nat Commun; 2024 May; 15(1):4162. PubMed ID: 38755139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant.
    Liu Y; Liu J; Johnson BA; Xia H; Ku Z; Schindewolf C; Widen SG; An Z; Weaver SC; Menachery VD; Xie X; Shi PY
    Cell Rep; 2022 May; 39(7):110829. PubMed ID: 35550680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.
    Gellenoncourt S; Saunders N; Robinot R; Auguste L; Rajah MM; Kervevan J; Jeger-Madiot R; Staropoli I; Planchais C; Mouquet H; Buchrieser J; Schwartz O; Chakrabarti LA
    J Virol; 2022 Oct; 96(19):e0130122. PubMed ID: 36121299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease.
    Stevaert A; Van Berwaer R; Mestdagh C; Vandeput J; Vanstreels E; Raeymaekers V; Laporte M; Naesens L
    mBio; 2022 Aug; 13(4):e0137622. PubMed ID: 35913162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis.
    Johnson BA; Xie X; Bailey AL; Kalveram B; Lokugamage KG; Muruato A; Zou J; Zhang X; Juelich T; Smith JK; Zhang L; Bopp N; Schindewolf C; Vu M; Vanderheiden A; Winkler ES; Swetnam D; Plante JA; Aguilar P; Plante KS; Popov V; Lee B; Weaver SC; Suthar MS; Routh AL; Ren P; Ku Z; An Z; Debbink K; Diamond MS; Shi PY; Freiberg AN; Menachery VD
    Nature; 2021 Mar; 591(7849):293-299. PubMed ID: 33494095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein.
    Kishimoto M; Uemura K; Sanaki T; Sato A; Hall WW; Kariwa H; Orba Y; Sawa H; Sasaki M
    Viruses; 2021 Feb; 13(3):. PubMed ID: 33671076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational modeling of the effect of five mutations on the structure of the ACE2 receptor and their correlation with infectivity and virulence of some emerged variants of SARS-CoV-2 suggests mechanisms of binding affinity dysregulation.
    Rodriguez JA; Gonzalez J; Arboleda-Bustos CE; Mendoza N; Martinez C; Pinzon A
    Chem Biol Interact; 2022 Dec; 368():110244. PubMed ID: 36336003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spike Protein Cleavage-Activation in the Context of the SARS-CoV-2 P681R Mutation: an Analysis from Its First Appearance in Lineage A.23.1 Identified in Uganda.
    Lubinski B; Frazier LE; Phan MVT; Bugembe DL; Cunningham JL; Tang T; Daniel S; Cotten M; Jaimes JA; Whittaker GR
    Microbiol Spectr; 2022 Aug; 10(4):e0151422. PubMed ID: 35766497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition.
    Navaratnarajah CK; Pease DR; Halfmann PJ; Taye B; Barkhymer A; Howell KG; Charlesworth JE; Christensen TA; Kawaoka Y; Cattaneo R; Schneider JW;
    J Virol; 2021 Nov; 95(24):e0136821. PubMed ID: 34613786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion.
    Ren W; Ju X; Gong M; Lan J; Yu Y; Long Q; Kenney DJ; O'Connell AK; Zhang Y; Zhong J; Zhong G; Douam F; Wang X; Huang A; Zhang R; Ding Q
    mBio; 2022 Apr; 13(2):e0009922. PubMed ID: 35266815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Omicron BA.1 Variant Infection of Human Colon Epithelial Cells.
    Antia A; Alvarado DM; Zeng Q; Casorla-Perez LA; Davis DL; Sonnek NM; Ciorba MA; Ding S
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.